Trial Profile
A Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf (Tacrolimus)/MMF [mycophenolate mofetil] and Extended Release (XL) [extended-release] Tacrolimus /MMF and Steroid Withdraw in de Novo Liver Transplant Recipients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2009
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 16 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Sep 2009 Actual patient number (48) added as reported by ClinicalTrials.gov.